Tourangeau Greg sold FULC
March 8, 2024 · Form 4 insider transaction
Tourangeau Greg sold 4,884 shares of Fulcrum Therapeutics, Inc. at $11.72 per share, a transaction worth $57.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.74, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.; Includes 699 shares acquired under the Issuer's employee stock purchase plan on May 13, 2022.